Misuse or abuse of methylphenidate may result in serious (possibly fatal) heart and blood pressure problems.
Methylphenidate should be given cautiously to emotionally unstable patients, especially if there is a history of alcohol or drug abuse. These patients may be more likely to unnecessarily increase their doses or use this medication too often. Long-term overuse of this medication may lead to drug...
Read moreThe Food and Drug Administration (FDA) recently issued safety announcement for Celexa (citalopram hydrobromide), an antidepressant... Read more »
We have been talking a lot about medications here on ADHD Central lately. Part of the reason for this is that so many of you write in with... Read more »
The U.S. Food and Drug Administration has approved Daytrana for use in teens between the ages of 13 to 17. The transdermal patch is already approved... Read more »
Brand Name: Daytrana Generic Name: methylphenidate Usage The U.S. Food and Drug Administration (FDA) have approved Daytrana for the treatment... Read more »
Drugmaker Shire has announced a recall of 39 lots of Daytrana, saying patients may have trouble removing the protective liner from the patch. The... Read more »
Data presented at a recent conference has given positive news about Daytrana, the new patch to treat attention-deficit/hyperactivity disorder (ADHD).... Read more »
A new study financed by the maker of the Daytrana patch found it reduced symptoms of attention-deficit/hyperactivity disorder in boys and girls ages... Read more »